Acquired anti-VIII antibodies : A new case;Auto-anticorps acquis anti-facteur VIII humain : Une nouvelle observation

Journal des Maladies Vasculaires

Volumn 21, Issue 5, 1996, Pages 324-328

  Cailleux, N ^a   Levesque, H ^a   Courtois, H ^a   Borg, J Y ^b  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Acquired inhibitors of blood coagulation; Hemophilia; Thromboplastin time; Von Willebrand disease

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEMOPHILIA; HUMAN; THROMBOPLASTIN TIME; VON WILLEBRAND DISEASE;

ADULT; AUTOANTIBODIES; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PREGNANCY; PROTHROMBIN TIME; RISK FACTORS;

EID: 0030477055     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ALARCON-SEGOVIA D, DELEZE M, ORIA CV, SANCHEZ-GUERRERO J, GOMEZ-PACHECO L, CABIEDES J, FERNANDEZ L, PONCE DE LEON S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medecine 1989 ; 68 : 353-65.
2. DESPOSITO F., ARKEL YS. Acquired anticoagulants (inhibitors) in hemophilic and nonhemophilic children. Int J Pediatr Hematol-Oncol 1993 ; 1 : 93-109.
3. DOUGHTY HA, NORTHEAST A, SKLAIR L, ROQUES T, YOUNG AE, SAVIDGE GF., HUNT BJ. The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery. Blood Coag Fibrinol 1995 ; 6 : 125-8.
4. DURAN-SAUREZ JR. Acquired hemophilia. Lancet, 1981 ; i : 255.
5. EXNER T, TRIPLETT DA, TABERNER D, MACHIN SJ. Guidelines to testing and revised criteria for lupus anticoagulants. Thromb Haemost 1991 ; 65 : 302-22.
6. 10, 2-1988, 12 p.
7. GREEN D, LECHNER K. A survey of 215 non hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1987 ; 58 : 1005-7.
8. GREEN D, LECHNER K. A survey of 215 non-haemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981 ; 45 : 200-3.
9. HULTIN MB. Acquired inhibitors in malignant and nonmalignant disease states. Am J Med 1991 ; 91 (Suppl. 5) : 9-13.
10. INGERSLEV J. A sensitive ELISA for von Willebrand factor (vWF :Ag). Scand J Clin Invest 1987 ; 47 : 143-7.
11. KAUFMAN RJ, WASLEY LC, DAVIES MV, WISE RJ, ISRAEL DI, DORNER AJ. Effect of vWF coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell Biol 1989 ; 9 : 1233-42
12. KESSLER CM. An introduction to factor VIII inhibitors : the detection and quantitation. Am J Med 1991 ; 91 (Suppl. 5), 1-5.
13. KESSLER CM. Symposium on acquired factor VIII inhibitors. Am J Med 1991 ; 91 (Suppl. 5) : 1-47.
14. KOEDAM JA, HAMER RJ, BEESER-VISSER NH, BOUMA BN, SIXMA JJ. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 1990 ; 189 : 229-34.
15. LÈ THI HUONG DU, GUILLEVIN L, BORG JY, BESANCENOT JF, LE Roux G, MALLEIN F, AUROUSSEAU MH, MAHIEU M, LE TALLEC Y, GUILMOT JL, WIEDERKEHR JL, KLEINKNECHT D, COURET B, FUZIBET JG, VITAL-DURAND D, ROUSSET H, SCHVED JF, THERY C, WISSEL ML, CORTET P. Anticoagulants circulants en dehors de l'hémophilie. Enquête multicentrique conduite par le Secrétariat à la recherche de la SNFMI à propos de 207 observations. Rev Méd Interne 1988 ; 9 : 3.3-9.
16. LÉVESQUE H, BORG JY, CAILLEUX N, VASSE M, GANCEL A, COURTOIS H. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Eur J Med 1993 ; 2 : 287-8.
17. LIAN ECY, LARCADA AF, CHIU AYZ. Combination immunossuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989 ; 110 : 774-8.
18. LOVE P, SANTORO S. Antiphospholipid antibodies : anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders : prevalence and clinical significance. Ann Intern Med 1990 ; 112 : 682-98.
19. MACFARLANE DE, STIBBE K, KIRBY EP., ZUCKER MB, GRANT RA, McPHERSON J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975 ; 34 : 306-8.
20. MANUCCI PM, LOMBARDI R, BADER R et al. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammapathies. Blood 1984 ; 64 : 614-21.
21. MANUCCI PM, RUGGERI ZM, PARETI FI, CAPITANIO A. 1-deamino-8-D-arginine vasopressine : a new pharmacological approach to the management of haemophilia and von Willebrand disease. Lancet 1977; i : 869-72.
22. MOREAU Ph, STAIKOWSKY F, LANEELLE D, DELLILE F, SIMONIN D, SCHIFFER C, LAURIAN Y. - Auto-anticorps acquis contre le facteur VIIIc humain. Traitement de deux accidents hémorragiques par le facteur VIIIc porcin. Presse Méd 1993 ; 22 : 472-9.
23. RATNOFF OD, SLOVER CC, POON MC. Immunologic evidence that the properties of human antihemophilic factor (factor VIII) are attributes of a single molecular species. Blood 1976 ; 47 : 657-67.
24. SCHWARTZ RS, GABRIEL DA, ALEDORT IM, GREEN D, KESSLER CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose gammaglobulin. Blood 1995 ; 86 : 797-804.
25. SHAPIRO SS, HULTIN M. Acquired inhibitors to the blood coagulation factors. Semin Thromb Haemost 1975 ; 1 : 336-85.
26. SULTAN Y. ALGIMAN M. Treatment of factor VIII inhibitors. Blood Coag Fibrinol 1990 ; 1 : 193-200.
27. WEISS HJ, TURITTO VT, BAUMGARTNER HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I : Shear rate-dependent increase of adhesion in von Willebrand disease and the Bernars-Soulier syndrome. J Lab Clin Med 1978 ; 92 : 750-64.
28. WHITE GC, MACMILLAN CW, BLATT PM, ROBERTS HR. Factor VIII inhibitors: a clinical overview. Am J Hematol 1982 ; 13 : 335-42.